BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23288643)

  • 41. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of SOX11 transcription factor. Its implication in mantle cell lymphoma].
    Roisman A; Slavutsky I
    Medicina (B Aires); 2014; 74(2):140-6. PubMed ID: 24736261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic alterations and cancer: new targets for therapy.
    Allen A
    IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
    Murgo AJ
    Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histone deacetylases and epigenetic therapies of hematological malignancies.
    Mercurio C; Minucci S; Pelicci PG
    Pharmacol Res; 2010 Jul; 62(1):18-34. PubMed ID: 20219679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epigenetics and cancer].
    Deltour S; Chopin V; Leprince D
    Med Sci (Paris); 2005 Apr; 21(4):405-11. PubMed ID: 15811306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Research Progress of Histone Modification in B Cell Lymphoma Pathogenesis-Review].
    Zhang J; Pan Y; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):615-620. PubMed ID: 29665942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant epigenetic gene regulation in lymphoid malignancies.
    Taylor KH; Briley A; Wang Z; Cheng J; Shi H; Caldwell CW
    Semin Hematol; 2013 Jan; 50(1):38-47. PubMed ID: 23507482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into novel emerging epigenetic drugs in myeloid malignancies.
    Chandhok NS; Prebet T
    Ther Adv Hematol; 2019; 10():2040620719866081. PubMed ID: 31431820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
    Gaál Z
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Migration and Adhesion of B-Lymphocytes to Specific Microenvironments in Mantle Cell Lymphoma: Interplay between Signaling Pathways and the Epigenetic Landscape.
    Sadeghi L; Wright AP
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic control of the tumor microenvironment.
    Marks DL; Olson RL; Fernandez-Zapico ME
    Epigenomics; 2016 Dec; 8(12):1671-1687. PubMed ID: 27700179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic diversity in hematopoietic neoplasms.
    Shaknovich R; De S; Michor F
    Biochim Biophys Acta; 2014 Dec; 1846(2):477-84. PubMed ID: 25240947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer Progenitor Cells: The Result of an Epigenetic Event?
    Lapinska K; Faria G; McGonagle S; Macumber KM; Heerboth S; Sarkar S
    Anticancer Res; 2018 Jan; 38(1):1-6. PubMed ID: 29277749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.